Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects

被引:88
作者
Torres, MST
Ramirez, L
Simkin, PH
Braverman, LE
Emerson, CH
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol & Metab, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Dept Radiol, Div Nucl Med, Worcester, MA 01655 USA
关键词
D O I
10.1210/jc.86.4.1660
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recombinant human TSH (rhTSH), usually given as 0.9-mg doses im on 2 successive days, increases serum thyroglobulin (Tg) and radioactive iodine uptake (RAIU) in residual thyroid tissue in patients with thyroid cancer. We previously reported that a single, relatively low dose of rhTSH (0.1 mg im) is a potent stimulator of T-4, T-3, and Tg secretion in normal subjects. The present study describes the effects of higher doses of rhTSH on thyroid hormone and Tg secretion. Six normal subjects for each dose group, having no evidence of thyroid disease, received either 0.3 or 0.9 mg rhTSH by im injection. Serum TSH, T-4, T-3, and Tg concentrations were measured at 2, 4, and 8 h and 1, 2, 3, 4, and 7 days after rhTSH administration. The peak serum TSH concentrations were 82 +/- 18 and 277 +/- 89 mU/L, respectively, for the 0.3- and 0.9-mg doses of rhTSH. Serum T-4, T-3, and Tg concentrations increased significantly in subjects receiving 0.3 and 0.9 mg rhTSH, with significant increases in T-4 and T-3 being observed before significant increases in serum Tg. Peak concentrations of serum T-4, T-3, and Tg, after 0.3 mg rhTSH administration, were 100 +/- 19, 131 +/- 14, and 1035 +/- 724% above individual baselines, respectively. Similarly, peak concentrations of serum T-4, T-3, and Tg, after 0.9 mg rhTSH administration, were 102 +/- 16, 134 +/- 7, and 1890 +/- 768% above individual baselines, respectively. These data, compared with previously reported data for the responses to 0.1 mg rhTSH, indicated that 0.1, 0.3. and 0.9 mg rhTSH had similar quantitative stimulatory effects on thyroid hormone and Tg secretion, except that the T-4 response was greater in groups receiving 0.3 and 0.9 mg rhTSH than in the group receiving 0.1 mg rhTSH. We also studied the effect of rhTSH on the thyroid RAIU in the group that received 0.9 mg rhTSH. The 6- and 24-h RAIU values were significantly higher after rhTSH (pre-rhTSH, 6-h value = 12.5 +/- 1.8%; 24 h value = 23 +/- 2.7%; post-rhTSH, 6 h value = 27 +/- 4.8%; 24-h value = 41 +/- 4.2%). The stimulating effects of 0.9 mg rhTSH on the 6- and 24-h RAIUs were similar, rhTSH is a potent stimulator of T-4, T-3, and Tg secretion and the RAIU in normal subjects. Single doses greater than 0.1-0.3 mg do not seem to further enhance thyroid hormone or Tg secretion.
引用
收藏
页码:1660 / 1664
页数:5
相关论文
共 25 条
  • [1] BENUA RS, 1964, J NUCL MED, V5, P796
  • [2] THYROTROPHIN STIMULATION TEST
    BURKE, G
    [J]. ANNALS OF INTERNAL MEDICINE, 1968, 69 (06) : 1127 - +
  • [3] THYROIDAL RELEASE AFTER ORAL-ADMINISTRATION OF TRH IN NORMAL SUBJECTS
    GOLSTEIN, J
    GLINOER, D
    BONNYNS, M
    VANHAELST, L
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1983, 6 (05) : 385 - 387
  • [4] Novel insights into the molecular mechanisms of human thyrotropin action: Structural, physiological, and therapeutic implications for the glycoprotein hormone family
    Grossmann, M
    Weintraub, BD
    Szkudlinski, MW
    [J]. ENDOCRINE REVIEWS, 1997, 18 (04) : 476 - 501
  • [5] A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
    Haugen, BR
    Pacini, F
    Reiners, C
    Schlumberger, M
    Ladenson, PW
    Sherman, SI
    Cooper, DS
    Graham, KE
    Braverman, LE
    Skarulis, MC
    Davies, TF
    DeGroot, LJ
    Mazzaferri, EL
    Daniels, GH
    Ross, DS
    Luster, M
    Samuels, MH
    Becker, DV
    Maxon, HR
    Cavalieri, RR
    Spencer, CA
    McEllin, K
    Weintraub, BD
    Ridgway, EC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) : 3877 - 3885
  • [6] SUPPRESSION OF HUMAN THYROID FUNCTION BY ANTIBODIES TO BOVINE THYROTROPIN
    HAYS, MT
    SOLOMON, DH
    BEALL, GN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (11) : 1540 - +
  • [7] Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter
    Huysmans, DA
    Nieuwlaat, WA
    Erdtsieck, RJ
    Schellekens, AP
    Bus, JW
    Bravenboer, B
    Hermus, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) : 3592 - 3596
  • [8] MECHANISM OF ALLERGY TO COMPONENTS OF COMMERCIAL BOVINE THYROTROPIN
    KIRKPATRICK, CH
    MEEK, JC
    RICH, RR
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1973, 51 (05) : 296 - 302
  • [9] KRISHNAMURTHY GT, 1978, J NUCL MED, V19, P284
  • [10] Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
    Ladenson, PW
    Braverman, LE
    Mazzaferri, EL
    BruckerDavis, F
    Cooper, DS
    Garber, JR
    Wondisford, FE
    Davies, TF
    DeGroot, LJ
    Daniels, GH
    Ross, DS
    Weintraub, BD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) : 888 - 896